Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Neuropharmacology. 2012 Jul 25;63(6):1022–1027. doi: 10.1016/j.neuropharm.2012.07.026

Figure 5. Effect of the 5-HT2A/C antagonist ketanserin on the MDMA-evoked increase in hippocampal glutamate efflux.

Figure 5

Rats received ketanserin (3 mg/kg, i.p.) or vehicle 30 min prior to the first injection of MDMA (10 mg/kg, i.p.) or vehicle, then one h after the second injection of MDMA or vehicle. (n =5–13 per group) * indicates values that differ significantly (P<0.05) from those for animals that received VEH+MDMA